Anti-PF4/polyanion antibodies in COVID-19 patients are associated with disease severity and pulmonary pathology
Thromboembolic events are frequent and associated with poor outcome in severe COVID-19 disease. Anti-PF4/polyanion antibodies are related to heparin-induced thrombocytopenia (HIT) and thrombus formation, but data on these antibodies in unselected COVID-19 populations are scarce. We assessed the pres...
Wedi'i Gadw mewn:
| Prif Awduron: | , , , , , , , , , , , , , , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Taylor & Francis Group
2022-05-01
|
| Cyfres: | Platelets |
| Pynciau: | |
| Mynediad Ar-lein: | http://dx.doi.org/10.1080/09537104.2022.2042238 |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|
